Sign In
Buy ILMN
$205.10
+0.0100 (+0.0049%)
At Close: Jul 31, 2026
FTC urges judge to unwind $7.1 billion Illumina-Grail merger
03:32pm, Tuesday, 24'th Aug 2021
The U.S. Federal Trade Commission on Tuesday said it seeks to unwind life science company Illumina Inc's $7.1 billion acquisition of Grail Inc, alleging it would harm innovation and boost prices.
7 Great Growth Stocks to Buy Now to Build Your Portfolio
11:58am, Tuesday, 24'th Aug 2021
These growth stocks could boost growth portfolios in the coming quarters The post 7 Great Growth Stocks to Buy Now to Build Your Portfolio appeared first on InvestorPlace. More From InvestorPlace Stoc
FTC Case Against Illumina's Grail Acquisition Begins Today. What to Know.
07:38am, Tuesday, 24'th Aug 2021
Opening arguments begin Tuesday in the government's antitrust case against Illumina's acquisition of cancer-screening pioneer Grail.
Will Illumina Stock Rebound After A 6% Fall Last Week?
06:30am, Tuesday, 24'th Aug 2021
The stock price of Illumina, a gene sequencing company, reached an all-time high of $524 earlier this month before a recent sell-off drove the stock price down 6% to its current level of around $487.
Illumina (ILMN) Shares Slip on GRAIL Buyout Deal Completion
03:05am, Monday, 23'rd Aug 2021
Illumina (ILMN) acquisition of GRAIL will expand patient access to life-saving multi-cancer early-detection test.
Illumina CEO on why the company moved forward with Grail deal, in spite of FTC challenge
05:15pm, Friday, 20'th Aug 2021
Frances deSouza, Illumina CEO, joins Power Lunch to discuss his company's deal to buy cancer diagnostics company Grail, in spite of a challenge from the FTC. For access to live and exclusive video fro
Illumina in EU antitrust sights over premature $8 billion Grail deal
06:27am, Friday, 20'th Aug 2021
U.S. life sciences company Illumina could face a hefty fine for jumping the gun by completing its $8 billion cash-and-stock takeover of cancer detection test maker Grail without first securing EU anti
Illumina's stock suffering biggest selloff in a year after warning of fines for closing GRAIL merger too soon
01:55pm, Thursday, 19'th Aug 2021
Shares of Illumina Inc. ILMN, -9.86% tumbled 9.8% in afternoon trading Thursday, enough to pace the S&P 500's SPX, +0.01% decliners, after the life sciences tools disclosed that it is likely to be fin
Illumina Completes Grail Buyout Despite Uncertainty In Regulatory Process
09:49am, Thursday, 19'th Aug 2021
In defiance of FTC and EU scrutiny, Illumina Inc (NASDAQ: ILMN) went ahead to complete its $8 billion acquisition of Grail. The finalization of the buyout comes as the FTC sued to block the move i
Illumina closes $7.1 billion deal for cancer test maker Grail amid regulatory hurdles
06:54pm, Wednesday, 18'th Aug 2021
Illumina Inc has completed its $7.1 billion acquisition of cancer detection test maker Grail Inc, it said on Wednesday amid challenges posed by the U.S. Federal Trade Commission and the European Union
Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
04:38pm, Wednesday, 18'th Aug 2021
SAN DIEGO, Aug. 18, 2021 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, b
Illumina Delivers a Beat and a Raise in Q2
08:12am, Saturday, 14'th Aug 2021
According to CEO Francis deSouza, the genetic life-sciences company is "firing on all cylinders."
EU Regulators Temporarily Pause Illumina, Grail Deal Investigation
03:21pm, Thursday, 12'th Aug 2021
The European Commission has temporarily suspended the provisional deadline for its investigation into Illumina Inc's (NASDAQ: ILMN) plans to buy Grail Inc, adding uncertainty to whether regulators
What Does the Future Look Like for Illumina Stock?
06:00am, Wednesday, 11'th Aug 2021
The leader in the genomics space is being treated like a monopoly, and is now running into federal regulation and oversight.
Why Does Illumina Want to Reunite With Grail?
05:00pm, Sunday, 08'th Aug 2021
The genomics leader might be hitting a ceiling in its original business.
